SAN FRANCISCO, Jan. 27, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative ...

Leerink Partners maintained a Market Perform rating on CVS Health (NYSE:CVS) shares while increasing the price target from ...

A Wall Street Journal report noted that a prospective deal between Walgreens and New York private-equity firm Sycamore ...

In a report released on January 24, Daina Graybosch from Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research ...

In a report released on January 24, Joseph Schwartz from Leerink Partners reiterated a Buy rating on Insmed (INSM – Research Report), with a ...

Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial ...

Sources told CNBC's David Faber that a private equity firm's prospective deal to acquire Walgreens Boots Alliance is ...

JP Morgan has recently reduced Progyny Inc (PGNY) stock to Neutral rating, as announced on December 2, 2024, according to Finviz. Earlier, on November 13, 2024, Truist had reduced the stock from a Buy ...

Inari Medical Inc (NARI) stock saw a modest uptick, ending the day at $79.74 which represents a slight increase of $0.28 or 0.35% from the prior close of $79.46. The stock opened at $79.54 and touched ...

The Wall Street Journal previously reported that Walgreens and Sycamore Partners were discussing a deal that could be ...

The decline in 89bio's stock price reflects investor reaction to the potential dilution of shares due to the proposed offering. When a company issues additional stock, it can lead to a reduction in ...

Intuitive Surgical (NASDAQ:ISRG – Free Report) had its target price boosted by JPMorgan Chase & Co. from $575.00 to $675.00 ...